MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress » MSA, PSP, CBS: Neuroimaging

Meeting: 2025 International Congress

Association between Imaging Glymphatic Dysfunction Markers and Clinical Symptoms in Progressive Supranuclear Palsy

J. Pardo, C. Martín-Barceló, C. Falcon, R. Sala-Llonch, I. Roura, A. Campabadal, N. Bargalló, C. Painous, M. Fernández, O. Brengaret, C. Brenlla, A. Cámara, E. Muñoz, F. Valldeoriola, MJ. Martí, Y. Compta, C. Junqué, B. Segura (Barcelona, Spain)

Brain Cholinergic Changes in Progressive supranuclear palsy: A single-subject voxel-wise approach to understanding heterogeneity

P. Kanel, G. Carli, J. Barr, R. Vangel, A. Narkis, C. Spears, P. Scott, R. Albin, N. Bohnen (Ann. Arbor, USA)

Brain perfusion patterns associated with motor symptoms in multiple system atrophy

Y. Nakano, A. Sugiyama, S. Hirano, Y. Nakagawa, M. Tamura, T. Yamamoto, Y. Koizumi, Y. Suzuki, K. Yamagishi, Y. Chishiki, S. Kuwabara, Y. Kitayama (Chiba, Japan)

Clinical and Dopaminergic Characteristics of MSA-C Patients with Predominant Cerebellar Asymmetry

DG. Park, YS. Kim, YS. An, JH. Yoon (Suwon, Republic of Korea)

Compensatory Dynamic Brain Network Mechanisms in Early Lewy Body Dementia: An rs-fMRI Study

N. Němcová Elfmarková, ľ. Nováková, M. Gajdoš, I. Rektorová (Brno, Czech Republic)

Connectome of Pathology Stages of Progressive Supranuclear Palsy

N. Vallenas, H. Tanaka, S. Lee, G. Kovacs, B. Couto (New York, USA)

Differences Between Clinical and Imaging Phenotypes in Phase 2 Study of ATH434 in Multiple System Atrophy

P. Trujillo, K. Hett, M. Bradbury, C. Wong, D. Stamler, D. Claassen (Nashville, USA)

Differentiating White-Matter Damage Patterns by Underlying Pathology in Corticobasal Syndrome

J. Parmera, A. Hernandez, B. Iepsen, C. Carneiro, S. Brucki, A. Coutinho (São Paulo, Brazil)

Functional Alterations in Early-Stage Parkinson’s Disease and Multiple System Atrophy with REM Sleep Behavior Disorder

SC. Wang, Y. Xiao, YB. Hou, CY. Li, RW. Ou, JY. Lin, TM. Yang, NN. Che, QR. Jiang, XT. Zheng, JY. Liu, HF. Shang (Chengdu, Sichuan, China)

Metabolic Patterns in Multiple System Atrophy: Brain Network Insights from Spatial ICA of FDG-PET

J. Li, H. Wang, B. Wang, Z. Cen, W. Luo (Hangzhou, China)

Multimodal imaging Integrating 18F-APN-1607 and 18F-FP-DTBZ PET in Progressive Supranuclear Palsy

C. Dong, J. Ma, S. Liu (Beijing, China)

Simple linear measurements of the putamen reliably differentiate MSA from other parkinsonian disorders on MRI.

T. Rohringer, V. Lam Shin-Cheung, P. Alcaide-Leon (Toronto, Canada)

The heterogenous compatibility of FDG-PET patterns and tau deposition in vivo in patients with Corticobasal Syndrome

X. Li, JY. Lu, FT. Liu, J. Wang (Shanghai, China)

The Radiographic Overlap Between Normal Pressure Hydrocephalus (NPH) and Progressive Supranuclear Palsy (PSP): When Looks Can Be Deceiving

R. Mani, C. Pol, M. Egnor, G. Schwartz (Stony Brook, USA)

Topographical heterogeneity of cholinergic system status in Multiple System Atrophy: A series report

A. Narkis, G. Carli, J. Barr, R. Vangel, C. Spears, R. Albin, P. Kanel, N. Bohnen (Ann Arbor, USA)

White Matter Abnormalities in Progressive Supranuclear Palsy (PSP) vs. Parkinson’s Disease (PD): Evaluation with a Convolutional Neural Network (CNN)-Based Tool

S. Zaheer, Y. Patel, M. Abarghouei Emamikhah, N. Bendahan, R. Zou, M. Malik, N. Owsicki, N. Paul, Q. Nguyen Victor, A. Boutet, A. Lang (Toronto, Canada)

« View all sessions from the 2025 International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley